Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Teva stock drops on guidance, manufacturing problems - MarketWatch
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Celltrion FDA warning causes headache for Teva's biologics ambition
Teva Pharmaceutical Works Private Limited Company 10/13/16
Teva China API plant smacked by FDA warning letter, adding to drugmaker's burdens
Teva's struggling sterile plant hit with FDA warning letter - Skyland Analytics
Filling errors, counterfeit packs gain FDA's attention | Packaging World
FDA Warns Teva API Plant in China | RAPS
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Site Inspections | Teva api
Teva expects FDA preapproval inspection of troubled Celltrion plant this year | Fierce Pharma
Teva Recalls One Lot Of IDArubicin Hydrochloride Injection
Teva Recalls U.S.-Made Drugs Following Contamination Fears | 2021-10-04 | SupplyChainBrain
Cheap Prescription Drugs in U.S. Can Have Hidden Cost - Bloomberg
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
FDA to share full inspection reports with EU; Difficult week for Teva, J&J, Mylan | Radio Compass Blog
UPDATED: Teva's struggling sterile plant hit with FDA warning letter | Fierce Pharma
Teva months from restarting production at Hungary plant banned by US FDA
Teva Pharma Suspends Irvine Production After FDA Probe - Orange County Business Journal
After Ignoring Letters From US FDA, Teva And Cipla Will Have ANDAs Withdrawn :: Pink Sheet
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
